These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1168 related items for PubMed ID: 10495374

  • 1. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
    Drake L, Hordinsky M, Fiedler V, Swinehart J, Unger WP, Cotterill PC, Thiboutot DM, Lowe N, Jacobson C, Whiting D, Stieglitz S, Kraus SJ, Griffin EI, Weiss D, Carrington P, Gencheff C, Cole GW, Pariser DM, Epstein ES, Tanaka W, Dallob A, Vandormael K, Geissler L, Waldstreicher J.
    J Am Acad Dermatol; 1999 Oct; 41(4):550-4. PubMed ID: 10495374
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of androgens in the scalp hair and plasma of patients with male-pattern baldness before and after finasteride administration.
    Ryu HK, Kim KM, Yoo EA, Sim WY, Chung BC.
    Br J Dermatol; 2006 Apr; 154(4):730-4. PubMed ID: 16536818
    [Abstract] [Full Text] [Related]

  • 3. Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss.
    Roberts JL, Fiedler V, Imperato-McGinley J, Whiting D, Olsen E, Shupack J, Stough D, DeVillez R, Rietschel R, Savin R, Bergfeld W, Swinehart J, Funicella T, Hordinsky M, Lowe N, Katz I, Lucky A, Drake L, Price VH, Weiss D, Whitmore E, Millikan L, Muller S, Gencheff C.
    J Am Acad Dermatol; 1999 Oct; 41(4):555-63. PubMed ID: 10495375
    [Abstract] [Full Text] [Related]

  • 4. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
    Olsen EA, Hordinsky M, Whiting D, Stough D, Hobbs S, Ellis ML, Wilson T, Rittmaster RS, Dutasteride Alopecia Research Team.
    J Am Acad Dermatol; 2006 Dec; 55(6):1014-23. PubMed ID: 17110217
    [Abstract] [Full Text] [Related]

  • 5. Finasteride in the treatment of Japanese men with male pattern hair loss.
    Kawashima M, Hayashi N, Igarashi A, Kitahara H, Maeguchi M, Mizuno A, Murata Y, Nogita T, Toda K, Tsuboi R, Ueki R, Yamada M, Yamazaki M, Matsuda T, Natsumeda Y, Takahashi K, Harada S.
    Eur J Dermatol; 2004 Dec; 14(4):247-54. PubMed ID: 15319158
    [Abstract] [Full Text] [Related]

  • 6. Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies.
    Whiting DA.
    Eur J Dermatol; 2001 Dec; 11(4):332-4. PubMed ID: 11399540
    [Abstract] [Full Text] [Related]

  • 7. The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
    Dallob AL, Sadick NS, Unger W, Lipert S, Geissler LA, Gregoire SL, Nguyen HH, Moore EC, Tanaka WK.
    J Clin Endocrinol Metab; 1994 Sep; 79(3):703-6. PubMed ID: 8077349
    [Abstract] [Full Text] [Related]

  • 8. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
    Price VH, Roberts JL, Hordinsky M, Olsen EA, Savin R, Bergfeld W, Fiedler V, Lucky A, Whiting DA, Pappas F, Culbertson J, Kotey P, Meehan A, Waldstreicher J.
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
    [Abstract] [Full Text] [Related]

  • 9. [Therapy of androgenetic alopecia with finasteride. What must be considered in consultation and drug prescribing].
    Wolff H, Kunte C.
    MMW Fortschr Med; 1999 Sep 16; 141(37):38-40. PubMed ID: 10897972
    [Abstract] [Full Text] [Related]

  • 10. [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].
    Spinucci G, Pasquali R.
    Clin Ter; 1996 Jun 16; 147(6):305-15. PubMed ID: 8925640
    [Abstract] [Full Text] [Related]

  • 11. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
    Camacho FM, García-Hernández MJ, Fernández-Crehuet JL.
    Br J Dermatol; 2008 May 16; 158(5):1121-4. PubMed ID: 18363752
    [Abstract] [Full Text] [Related]

  • 12. Caspase-1 level is higher in the scalp in androgenetic alopecia.
    de Rivero Vaccari JP, Sawaya ME, Brand F, Nusbaum BP, Bauman AJ, Bramlett HM, Dietrich WD, Keane RW.
    Dermatol Surg; 2012 Jul 16; 38(7 Pt 1):1033-9. PubMed ID: 22404322
    [Abstract] [Full Text] [Related]

  • 13. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.
    Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ.
    J Am Acad Dermatol; 1998 Oct 16; 39(4 Pt 1):578-89. PubMed ID: 9777765
    [Abstract] [Full Text] [Related]

  • 14. Androgens and alopecia.
    Kaufman KD.
    Mol Cell Endocrinol; 2002 Dec 30; 198(1-2):89-95. PubMed ID: 12573818
    [Abstract] [Full Text] [Related]

  • 15. Increased scalp skin and serum 5 alpha-reductase reduced androgens in a man relevant to the acquired progressive kinky hair disorder and developing androgenetic alopecia.
    Boudou P, Reygagne P.
    Arch Dermatol; 1997 Sep 30; 133(9):1129-33. PubMed ID: 9301590
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss.
    Whiting DA, Olsen EA, Savin R, Halper L, Rodgers A, Wang L, Hustad C, Palmisano J, Male Pattern Hair Loss Study Group.
    Eur J Dermatol; 2003 Sep 30; 13(2):150-60. PubMed ID: 12695131
    [Abstract] [Full Text] [Related]

  • 17. Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia.
    Caserini M, Radicioni M, Leuratti C, Terragni E, Iorizzo M, Palmieri R.
    Int J Clin Pharmacol Ther; 2016 Jan 30; 54(1):19-27. PubMed ID: 26636418
    [Abstract] [Full Text] [Related]

  • 18. Effective treatment of female androgenic alopecia with dutasteride.
    Olszewska M, Rudnicka L.
    J Drugs Dermatol; 2005 Jan 30; 4(5):637-40. PubMed ID: 16167423
    [Abstract] [Full Text] [Related]

  • 19. Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.
    Price VH, Menefee E, Sanchez M, Kaufman KD.
    J Am Acad Dermatol; 2006 Jul 30; 55(1):71-4. PubMed ID: 16781295
    [Abstract] [Full Text] [Related]

  • 20. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
    Finasteride Male Pattern Hair Loss Study Group.
    Eur J Dermatol; 2002 Jul 30; 12(1):38-49. PubMed ID: 11809594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.